{"api":"v1","generated_at":"2026-10-01T02:32:50.545Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-nccn-ipi-550bfb","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-nccn-ipi-550bfb/at/2026-09-30T22-14Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-09-30T22:14:11.940Z","snapshot_stamp":"2026-09-30T22-14Z","endpoint":{"slug":"api-magentlab-com-api-calc-nccn-ipi-550bfb","canonical_url":"https://api.magentlab.com/api/calc/nccn_ipi","resource":"https://api.magentlab.com/api/calc/nccn_ipi","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"Zhou 2014 NCCN-IPI for DLBCL in the rituximab era: age (≤40 0, 41–60 1, 61–75 2, ≥76 3), LDH/ULN (≤1 0, >1–3 1, >3 2), Ann Arbor III or IV 1, major-organ extranodal (bone marrow, CNS, liver/GI tract, or lung) 1, ECOG ≥2 1; max 8. Low 0–1, low_intermediate 2–3, high_intermediate 4–5, high 6–8. Deterministic published score; not a DLBCL diagnosis or treatment choice; not Shipp IPI, not R-IPI, not CNS-IPI. magent does not assay LDH or stage lymphoma.","service_name":"magent","declared_category":null,"declared_tags":["nccn-ipi","lymphoma","hematology","dlbcl","prognosis"],"route_template":null,"registry_updated":"2026-09-28T15:08:29.577Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc nccn ipi","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-09-30T22:14:11.940Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-09-30T22:14:11.940Z","calls_30d":1,"unique_payers_30d":1,"last_called_at":"2026-09-28T15:08:29.311Z"},"validation":{"latest":{"observed_at":"2026-09-30T06:52:07.254Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-09-30"},"uptime":[{"days":7,"observed":4,"passed":4,"ratio":1},{"days":30,"observed":4,"passed":4,"ratio":1},{"days":90,"observed":4,"passed":4,"ratio":1}],"history_90d":[{"observed_at":"2026-09-30T06:52:07.254Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T19:10:57.009Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T16:56:19.787Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-28","state_changed":false},{"observed_at":"2026-09-28T16:42:13.125Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["nccn-ipi","lymphoma","hematology","dlbcl","prognosis"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/nccn_ipi","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T15:08:29.311Z","l30DaysTotalCalls":1,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/nccn_ipi","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"age":40,"ecog":0,"ldh_uln_ratio":0.9,"stage_iii_or_iv":false,"extranodal_major":false},{"age":40,"ecog":0,"ldh_uln_ratio":0.9,"stage_iii_or_iv":false,"extranodal_major":false}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/nccn_ipi","count":2,"items":[{"ecog":0,"score":0,"formula":"nccn_ipi","citation":{"id":"zhou-2014","doi":"10.1182/blood-2013-09-524108","pmid":"24264230","title":"An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era","source":"Blood. 2014;123(6):837-842","authors":"Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN"},"age_years":40,"max_score":8,"components":[{"value":40,"factor":"age","points":0,"present":false},{"value":0.9,"factor":"ldh_uln_ratio","points":0,"present":false},{"factor":"stage_iii_or_iv","points":0,"present":false},{"factor":"extranodal_major","points":0,"present":false},{"value":0,"factor":"ecog_ge_2","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","ldh_uln_ratio":0.9,"nccn_ipi_risk":"low","extranodal_major":false,"formula_expression":"NCCN-IPI = age (≤40 0, 41–60 1, 61–75 2, ≥76 3) + LDH/ULN (≤1 0, >1–3 1, >3 2) + stage_iii_or_iv 1 + extranodal_major 1 + ecog_ge_2 1; Zhou 2014; max 8; low 0-1, low_intermediate 2-3, high_intermediate 4-5, high 6-8"},{"ecog":0,"score":0,"formula":"nccn_ipi","citation":{"id":"zhou-2014","doi":"10.1182/blood-2013-09-524108","pmid":"24264230","title":"An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era","source":"Blood. 2014;123(6):837-842","authors":"Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW, Winter JN"},"age_years":40,"max_score":8,"components":[{"value":40,"factor":"age","points":0,"present":false},{"value":0.9,"factor":"ldh_uln_ratio","points":0,"present":false},{"factor":"stage_iii_or_iv","points":0,"present":false},{"factor":"extranodal_major","points":0,"present":false},{"value":0,"factor":"ecog_ge_2","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","ldh_uln_ratio":0.9,"nccn_ipi_risk":"low","extranodal_major":false,"formula_expression":"NCCN-IPI = age (≤40 0, 41–60 1, 61–75 2, ≥76 3) + LDH/ULN (≤1 0, >1–3 1, >3 2) + stage_iii_or_iv 1 + extranodal_major 1 + ecog_ge_2 1; Zhou 2014; max 8; low 0-1, low_intermediate 2-3, high_intermediate 4-5, high 6-8"}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["age","ecog","ldh_uln_ratio","stage_iii_or_iv","extranodal_major"],"properties":{"age":{"type":"integer","description":"Age in years (18-120). ≤40 scores 0; 41–60 scores 1; 61–75 scores 2; ≥76 scores 3 (Zhou 2014 NCCN-IPI refined age). Age 40 scores 0; 41 and 60 score 1; 61 and 75 score 2; 76 scores 3. Not Shipp IPI binary >60."},"ecog":{"type":"integer","description":"ECOG performance status 0-4 as assigned by the caller (Zhou 2014 NCCN-IPI). ≥2 scores 1. magent does not assign ECOG."},"ldh_uln_ratio":{"type":"number","description":"Serum LDH divided by the laboratory ULN (0.1-20). ≤1 scores 0; >1 and ≤3 scores 1; >3 scores 2 (Zhou 2014 NCCN-IPI). 1.0 scores 0; 1.01 and 3.0 score 1; 3.01 scores 2. magent does not assay LDH."},"stage_iii_or_iv":{"type":"boolean","description":"Ann Arbor stage III or IV as assigned by the caller (Zhou 2014 NCCN-IPI). true scores 1. magent does not stage lymphoma."},"extranodal_major":{"type":"boolean","description":"Extranodal involvement of major organs (bone marrow, CNS, liver/GI tract, or lung) as assigned by the caller (Zhou 2014 NCCN-IPI). true scores 1. This is not IPI extranodal sites >1. magent does not image extranodal sites."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"Zhou 2014 NCCN-IPI for DLBCL in the rituximab era: age (≤40 0, 41–60 1, 61–75 2, ≥76 3), LDH/ULN (≤1 0, >1–3 1, >3 2), Ann Arbor III or IV 1, major-organ extranodal (bone marrow, CNS, liver/GI tract, or lung) 1, ECOG ≥2 1; max 8. Low 0–1, low_intermediate 2–3, high_intermediate 4–5, high 6–8. Deterministic published score; not a DLBCL diagnosis or treatment choice; not Shipp IPI, not R-IPI, not CNS-IPI. magent does not assay LDH or stage lymphoma.","lastUpdated":"2026-09-28T15:08:29.577Z","serviceName":"magent","x402Version":2}]}}